Connection

Frank Brescia to Half-Life

Back to Details
This is a "connection" page, showing publications Frank Brescia has written about Half-Life.
Frank Brescia
Connection Strength
0.017
Half-Life
  1. A phase II study of milataxel: a novel taxane analogue in previously treated patients with advanced colorectal cancer. Cancer Chemother Pharmacol. 2008 Mar; 61(3):453-8.
    View in: PubMed
    Score: 0.017
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.